|
06-24-2010, 12:35 AM
|
|||
|
|||
UK's NICE rejects Glaxo, Genmab leukemia drug
GlaxoSmithKline leukemia drug Arzerra, licensed from Denmark's Genmab, has been rejected by Britain's cost watchdog NICE in preliminary draft guidance.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| UK's NICE Backs Roche's Herceptin In Metastatic Stomach Cancer | cancerfr | Stomach (Gastric) Cancer | 0 | 09-30-2010 02:52 AM |
| Glaxo kidney cancer drug shrinks thyroid tumors: study | cancerfr | Extracranial Germ Cell Tumor | 0 | 09-19-2010 04:01 AM |
| Glaxo kidney cancer drug shrinks thyroid | cancerfr | Extracranial Germ Cell Tumor | 0 | 09-19-2010 04:01 AM |
| UK's NICE rejects Roche's Avastin in breast cancer | cancerfr | Bone Cancer | 0 | 07-09-2010 03:36 PM |
| Bone drug from Amgen and Glaxo wins EU approval | cancerfr | Bone Cancer | 0 | 05-29-2010 03:53 PM |
Linear Mode
